These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16678991)

  • 1. Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.
    Moore DA; Caviedes L; Gilman RH; Coronel J; Arenas F; LaChira D; Salazar C; Carlos Saravia J; Oberhelman RA; Hollm-Delgado MG; Escombe AR; Evans CA; Friedland JS
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):35-43. PubMed ID: 16678991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic-observation drug-susceptibility assay for the diagnosis of TB.
    Moore DA; Evans CA; Gilman RH; Caviedes L; Coronel J; Vivar A; Sanchez E; Piñedo Y; Saravia JC; Salazar C; Oberhelman R; Hollm-Delgado MG; LaChira D; Escombe AR; Friedland JS
    N Engl J Med; 2006 Oct; 355(15):1539-50. PubMed ID: 17035648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia.
    Lora MH; Reimer-McAtee MJ; Gilman RH; Lozano D; Saravia R; Pajuelo M; Bern C; Castro R; Espinoza M; Vallejo M; Solano M; Challapa R; Torrico F
    BMC Infect Dis; 2015 Jun; 15():222. PubMed ID: 26047953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.
    Moore DA; Mendoza D; Gilman RH; Evans CA; Hollm Delgado MG; Guerra J; Caviedes L; Vargas D; Ticona E; Ortiz J; Soto G; Serpa J;
    J Clin Microbiol; 2004 Oct; 42(10):4432-7. PubMed ID: 15472289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
    Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
    J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.
    Lazarus RP; Kalaiselvan S; John KR; Michael JS
    Indian J Med Microbiol; 2012; 30(1):64-8. PubMed ID: 22361763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
    Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
    Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria.
    Ochang EA; Oduyebo OO; Onwuezobe IA; Collier D; Bode-Sojobi I; Odo M
    Niger J Med; 2016; 25(3):226-33. PubMed ID: 30011167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.
    Reddy KP; Brady MF; Gilman RH; Coronel J; Navincopa M; Ticona E; Chavez G; Sánchez E; Rojas C; Solari L; Valencia J; Pinedo Y; Benites C; Friedland JS; Moore DA
    Clin Infect Dis; 2010 Apr; 50(7):988-96. PubMed ID: 20192727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.
    Martin L; Coronel J; Faulx D; Valdez M; Metzler M; Crudder C; Castillo E; Caviedes L; Grandjean L; Rodriguez M; Friedland JS; Gilman RH; Moore DA
    PLoS One; 2014; 9(9):e107258. PubMed ID: 25225802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: A preliminary study.
    Huang Z; Xiong G; Luo Q; Jiang B; Li W; Xu X; Li J
    Respirology; 2014 Jan; 19(1):132-7. PubMed ID: 24103019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens.
    Phillips PPJ; Mendel CM; Nunn AJ; McHugh TD; Crook AM; Hunt R; Bateson A; Gillespie SH
    BMC Med; 2017 Nov; 15(1):207. PubMed ID: 29169355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda.
    Bwanga F; Haile M; Joloba ML; Ochom E; Hoffner S
    PLoS One; 2011 May; 6(5):e19565. PubMed ID: 21573015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum].
    Lu JM; Wang J; Huang XC; Hu ZY; Cui ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):21-5. PubMed ID: 21418814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India.
    Michael JS; Daley P; Kalaiselvan S; Latha A; Vijayakumar J; Mathai D; John KR; Pai M
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):482-8. PubMed ID: 20202307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.
    Makamure B; Mhaka J; Makumbirofa S; Mutetwa R; Mupfumi L; Mason P; Metcalfe JZ
    PLoS One; 2013; 8(2):e55872. PubMed ID: 23409072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-outbreak of multidrug-resistant Mycobacterium tuberculosis associated with presumed laboratory processing contamination.
    Bearman G; Vaamonde C; Larone D; Drusin L; Zuccotti G
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):620-2. PubMed ID: 12400894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.